(15055031), A. E., (15055034), L. S., (15055037), S. I. V., (15055040), L. A. H., (14947288), C. A. L., (15055043), V. F., . . . (14947294), C. L. (2025). Supplementary Table S4 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial.
Чикаго-гийн эшлэл (17 дахь хэвлэлт)(15055031), Andrés Elía, et al. Supplementary Table S4 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial. 2025.
MLA -ийн эшлэл (9 дэх хэвлэлт)(15055031), Andrés Elía, et al. Supplementary Table S4 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial. 2025.